高级检索
当前位置: 首页 > 详情页

Comparison between sub-lobar resection and lobar resection for clinical stage IA (tumor size ≤ 2 cm) lung invasive mucinous adenocarcinoma with tumor spread through air spaces: A multi-center real-world study

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [2]Department of Thoracic Surgery, Zhoushan Putuo District People’s Hospital, Zhoushan, China [3]Department of Thoracic Surgery, The First Affiliated Hospital of Shaoyang University, Shaoyang, China [4]Department of Anesthesiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China [5]Department of Cardiothoracic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China [6]Department of Cardiothoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China [7]Department of Integrated Traditional Chinese and Western Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China [8]Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [9]School of Life Science and Technology, ShanghaiTech University, Shanghai, China [10]Department of Cardiothoracic Surgery, Ningbo Beilun District People’s Hospital, Ningbo, China [11]Wenzhou People’s Hospital, Shanghai University, Wenzhou, China [12]Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
出处:
ISSN:

关键词: Lung invasive mucinous adenocarcinoma Spread through air spaces Sub-lobar resection Lobar resection Overall survival

摘要:
Tumor spread through air spaces (STAS) has emerged as a significant prognostic factor in clinical stage IA (cIA) invasive mucinous adenocarcinoma (IMA) of the lung. However, it remains unclear whether sub-lobar resection (SR) offers survival outcomes comparable to those of lobar resection (LR) in this cohort. This study aimed to assess the efficacy of SR in patients with STAS-positive cIA (tumor size ≤2 cm) IMA using large-scale, multi-center, real-world data.We retrospectively reviewed consecutive patients with peripheral cIA (≤2 cm) STAS-positive IMA who underwent SR or LR between 2012 and 2020 at seven high-volume institutions across five Chinese cities. The primary endpoint was overall survival (OS), and the secondary endpoint was recurrence-free survival (RFS). Propensity-score matching (PSM) was employed to mitigate selection bias.Among 567 included patients, PSM yielded 179 patients undergoing SR and 388 patients undergoing LR. Over a median follow-up of 6.2 years, SR demonstrated comparable 5-year OS (78.7 % versus 81.6 %, hazard ratio (HR) = 0.976, 95 % confidence interval (CI) = 0.693-1.375, P = 0.890) and RFS (69.0 % versus 71.8 %, HR = 1.017, 95 %CI = 0.752-1.376, P = 0.914) to LR. Subgroup analysis revealed that SR improved 5-year OS in patients aged ≥70 years (73.1 % versus 67.2 %, HR = 0.636, 95 %CI = 0.404-0.969, P = 0.040). Additionally, SR yielded similar outcomes in patients with visceral pleural invasion and exhibited a statistically nonsignificant trend toward lower survival in those with pathological N1-2 disease. Furthermore, LR, segmentectomy, and wedge resection yielded comparable 5-year OS and RFS.Among patients with cIA (≤2 cm) STAS-positive IMA, SR provides 5-year OS and RFS outcomes comparable to LR and may confer a survival advantage among patients aged ≥70 years. These findings support the efficacy of SR and suggest that it should not be considered an adverse prognostic factor in this patient cohort.Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 外科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 外科
第一作者:
第一作者机构: [1]Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:29059 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)